NEW YORK, NY--(Marketwired - April 27, 2017) - Artemis Therapeutics, Inc. (OTC PINK: ATMS), ("Artemis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of ...
Immunologic Response and Pathogenic Mechanisms of Cytomegalovirus Infection in Transplant Recipients
Immunity mechanisms of cytomegalovirus infection control have been studied recently and have contributed to the better understanding of the pathogenesis of this disease in patients with a solid organ ...
Cytomegalovirus (CMV) infection remains a common complication after allogeneic hematopoietic-cell transplantation. Letermovir is an antiviral drug that inhibits the CMV–terminase complex. In this ...
Cytomegalovirus (CMV) is a herpes virus. Infection can cause flu-like symptoms, although it is often symptomless. In people with weakened immune systems, it can reactivate and affect the eyes, lungs, ...
Atlanta, GA – Current research suggests that latent cytomegalovirus (CMV) infection may exacerbate inflammatory bowel disease (IBD). The related report by Onyeagocha et al, "Latent cytomegalovirus ...
Cytomegalovirus (CMV) is a common virus. According to the Centers for Disease Control and Prevention (CDC), it infects between 50 to 80 percent of all adults by the time they reach 40 years old.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results